Patient experiences of waiting times in standardised cancer patient pathways in Norway - a qualitative interview study

BMC Health Serv Res. 2021 Jul 5;21(1):651. doi: 10.1186/s12913-021-06679-8.

Abstract

Objective: Standardised cancer patient pathways (CPP) are implemented within cancer care with an aim to ensure standardised waiting times for diagnosis and treatment. This article investigates how patients in Norway experience waiting times within a CPP.

Methods: Qualitative semi-structured interviews with 19 patients who had been through CPP for breast cancer, prostate cancer or malignant melanoma in Norway.

Results: Few patients knew about the term CPP but trusted that waiting times were standardised to decrease mortality. Their experiences of waiting depended on their expectations as much as the period they waited. Patients generally felt safe about the timing of treatment, but not all expectations of a rapid response from health services were met. Short waiting times were interpreted as a sign of urgency, and a change of pace between urgent action and prolonged periods of waiting were disturbing.

Conclusions: Patients are comforted by knowing they are within a structured CPP that ensures rapid diagnosis and start of treatment. CPPs still need to be improved to avoid delays, allow for adaptions to patient needs, and include more information to avoid stress.

MeSH terms

  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / therapy
  • Humans
  • Male
  • Norway
  • Patient Outcome Assessment
  • Qualitative Research
  • Waiting Lists*